6551 - 6600 of 8436 Results
Title
Year
- Validation of Electrochemiluminescence Assays for Highly Sensitive and Reproducible Quantification of α-Synuclein in Cerebrospinal Fluid2017RESTRICTEDTitle: Validation of Electrochemiluminescence Assays for Highly Sensitive and Reproducible Quantification of α-Synuclein in Cerebrospinal FluidJournal Name: BioanalysisPublisher: Informa UK LimitedVol: 9Issue #: 8Start Page: 621End Page: 630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4155/bio-2017-0005Citation Count: 11
-
OPENTitle: Parkinson disease in Gaucher diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0054-2Best OA location URL: https://doi.org/10.1186/s40734-017-0054-2Citation Count: 13
-
RESTRICTEDTitle: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 18End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017Citation Count: 64
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 32
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies2017RESTRICTEDTitle: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 5Start Page: 726End Page: 738Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26964Citation Count: 58
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 73
- Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization2017OPENTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 84
- Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses2017OPENTitle: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0012-6Best OA location URL: https://www.nature.com/articles/s41531-017-0012-6.pdfCitation Count: 34
-
OPENTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://doi.org/10.1038/s41531-017-0010-8Citation Count: 231
- The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK22017OPENTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://europepmc.org/articles/pmc6178381?pdf=renderCitation Count: 34
- An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression2017OPENTitle: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 11Issue #: 7-8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.201700045Best OA location URL: https://europepmc.org/articles/pmc5540649?pdf=renderCitation Count: 19
-
OPENTitle: Cortical surface‐based threshold‐free cluster enhancement and cortexwise mediationJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 6Start Page: 2795End Page: 2807Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23563Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23563Citation Count: 22
- Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes2017OPENTitle: Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging PhenotypesJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 4Start Page: 404End Page: 415.e5Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2017.02.009Best OA location URL: http://www.cell.com/article/S2405471217300534/pdfCitation Count: 110
- Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology2017OPENTitle: Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathologyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 54Issue #:Start Page: 175End Page: 186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.007Best OA location URL: https://europepmc.org/articles/pmc5862548?pdf=renderCitation Count: 31
- Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease2017OPENTitle: Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 55Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.012Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2017.03.012Citation Count: 62
-
OPENTitle: TMEM230 in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 56Issue #:Start Page: 212.e1End Page: 212.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5526081Citation Count: 8
- Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum2017RESTRICTEDTitle: Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 6Start Page: 1861End Page: 1874Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-4937-0Citation Count: 48
- Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry2017OPENTitle: Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetryJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 6Start Page: 2875End Page: 2896Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23559Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23559Citation Count: 24
- Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice2017OPENTitle: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0426-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0426-8Citation Count: 87
-
RESTRICTEDTitle: Protein misfolding in neurodegenerative diseases: implications and strategiesJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-017-0077-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-017-0077-5Citation Count: 428
-
OPENTitle: Structure-guided mutagenesis reveals a hierarchical mechanism of Parkin activationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms14697Best OA location URL: https://www.nature.com/articles/ncomms14697.pdfCitation Count: 97
-
OPENTitle: A screening tool to detect clinical manganese neurotoxicityJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 64Issue #:Start Page: 12End Page: 18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.02.009Best OA location URL: https://europepmc.org/articles/pmc5587364?pdf=renderCitation Count: 6
- Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients2017OPENTitle: Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease PatientsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00038/pdfCitation Count: 57
- Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study2017OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 15
- Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff2017RESTRICTEDTitle: Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the ChaffJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 7Issue #: s1Start Page: S71End Page: S85Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-179001Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd179001?id=journal-of-parkinsons-disease%2Fjpd179001Citation Count: 290
-
OPENTitle: The Identification of Alpha-Synuclein as the First Parkinson Disease GeneJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: s1Start Page: S43End Page: S49Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-179003Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd179003?id=journal-of-parkinsons-disease%2Fjpd179003Citation Count: 66
-
RESTRICTEDTitle: Diagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick roadJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0052-4Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0052-4Citation Count: 28
-
OPENTitle: Consensus classification of posterior cortical atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 8Start Page: 870End Page: 884Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2017.01.014Best OA location URL: http://www.alzheimersanddementia.com/article/S1552526017300407/pdfCitation Count: 539
- Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic review2017RESTRICTEDTitle: Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1642End Page: 1654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-017-8424-0Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00415-017-8424-0.pdfCitation Count: 141
-
OPENTitle: Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent NeuronsJournal Name: eneuroPublisher: Society for NeuroscienceVol: 4Issue #: 2Start Page: ENEURO.0216End Page: 16.2017Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0216-16.2017Best OA location URL: https://www.eneuro.org/content/eneuro/4/2/ENEURO.0216-16.2017.full.pdfCitation Count: 15
-
RESTRICTEDTitle: Neuropsychiatric symptoms in untreated Parkinson’s diseaseJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 13Issue #:Start Page: 815End Page: 826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s130997Best OA location URL: https://www.dovepress.com/getfile.php?fileID=35506Citation Count: 41
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia2017OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 40
- Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers2017OPENTitle: Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 133Issue #: 5Start Page: 839End Page: 856Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-017-1685-yBest OA location URL: https://europepmc.org/articles/pmc5613285?pdf=renderCitation Count: 218
-
OPENTitle: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 5Start Page: 2627End Page: 2634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23547Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23547Citation Count: 49
-
OPENTitle: Targeted deletion of GD3 synthase protects against MPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 22
- Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials2017RESTRICTEDTitle: Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26913Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/40514/5/CONICET_Digital_Nro.82df6a72-6ca0-4e97-82ab-71e013c4c8bf_s.pdfCitation Count: 148
-
OPENTitle: Multi-modal and targeted imaging improves automated mid-brain segmentationJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254428Best OA location URL: https://europepmc.org/articles/pmc5544135?pdf=renderCitation Count: 2
-
OPENTitle: Multi-scale hippocampal parcellation improves atlas-based segmentation accuracyJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254425Best OA location URL: https://europepmc.org/articles/pmc5544133?pdf=renderCitation Count: 10
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 26
-
OPENTitle: Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's DiseaseJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 6Start Page: 578End Page: 585Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205014666170203093219Best OA location URL: https://europepmc.org/articles/pmc6091859?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 13
-
RESTRICTEDTitle: Post translational modification of ParkinJournal Name: Biology DirectPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13062-017-0176-3Best OA location URL: https://biologydirect.biomedcentral.com/track/pdf/10.1186/s13062-017-0176-3Citation Count: 43
- Classification of brain disease in magnetic resonance images using two-stage local feature fusion2017OPENTitle: Classification of brain disease in magnetic resonance images using two-stage local feature fusionJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 2Start Page: e0171749End Page: e0171749Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0171749Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171749&type=printableCitation Count: 13
-
OPENTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 85
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned2017RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 32
- Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice2017OPENTitle: Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system miceJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0158-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0158-zCitation Count: 55
- Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression2017OPENTitle: Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP ExpressionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 120Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/54981Best OA location URL: https://europepmc.org/articles/pmc5409190?pdf=renderCitation Count: 7
- AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models2017RESTRICTEDTitle: AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease ModelsJournal Name: GenesPublisher: MDPI AGVol: 8Issue #: 2Start Page: 63End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes8020063Best OA location URL: https://www.mdpi.com/2073-4425/8/2/63/pdf?version=1486965246Citation Count: 45
-
RESTRICTEDTitle: The LRRK2–macroautophagy axis and its relevance to Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 45Issue #: 1Start Page: 155End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bst20160265Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/45/1/155/432837/bst-2016-0265.pdfCitation Count: 61